In breast cancer cells and in solid autocrine human growth hormone (hGH) tumours, both WNT4 and its receptor FZD6 were upregulated (Vouyovitch et al., 2016) indicating that WNT4 is a strong Wnt ligand candidate to activate FZD6. Here, FZD6 is linked to breast cancer.